Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section

Launched by TANTA UNIVERSITY · Jun 23, 2025

Keywords

ClinConnect Summary

This clinical trial is studying whether adding a medicine called calcitonin to a common pain relief drug, bupivacaine, can improve pain control during a type of nerve block called the transversalis fascia plane block. This block is used to help manage pain for women having a cesarean section (C-section) with spinal anesthesia. The researchers want to see if this combination works better to reduce pain after surgery.

Women who are in generally good health (classified as ASA2) and are scheduled for a planned C-section under spinal anesthesia may be eligible to join the study. However, women who refuse to participate, have certain pregnancy-related diseases, emergency C-sections, or blood clotting problems are not eligible. Participants will receive the nerve block with the medicines guided by ultrasound, and the team will monitor how well it controls pain. This study is currently recruiting patients, so if you or a loved one fits the criteria and is interested, you can ask your doctor about it.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • female pt ASA2 scheduled for cs under spinal anesthesia
• Exclusion Criteria:
• • patient refusal ASAmore than 3 patients with pregnancy related disease emergency cs history of coagulopathy